A phase 2b randomised, double-blind, parallel-group study of alginate oligosaccharide (OligoG) dry powder inhalation in addition to standard of care compared to placebo in addition to standard of care in patients with Cystic Fibrosis (CF).

Project: Research

StatusActive
Effective start/end date23/05/1931/12/20

Keywords

  • Cystic Fibrosis
  • Allergy
  • Immunology
  • Clinical trial
  • Cystic Fibrosis
  • Allergy
  • Immunology
  • Clinical trial
  • Cystic Fibrosis
  • Allergy
  • Immunology
  • Clinical trial